Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for Initiation of a Global Phase 2 Trial for TransCon™ CNP in Children with Achondroplasia

July 18, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search